Esperion Therapeutics
ESPR
#6052
Rank
โ‚น85.74 B
Marketcap
โ‚น361.69
Share price
2.80%
Change (1 day)
90.09%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น85.74 Billion

As of December 2025 Esperion Therapeutics has a market cap of โ‚น85.74 Billion. This makes Esperion Therapeutics the world's 6052th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น85.74 B122.49%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Esperion Therapeutics was reported to be:

โ‚น86.46 Billion
by Nasdaq info icon info icon
โ‚น85.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น300.14 B 250.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.019 T 1,089.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น12.832 T 14,865.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.395 T 8,524.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น393.48 B 358.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น39.69 B-53.71%๐Ÿ‡บ๐Ÿ‡ธ USA